596161 Disclosed herein is a pharmaceutical composition comprising 2,4,6-trifluoro-N-[ 6-(1-methyl-piperdin-4-ylcarbonyl)-pyridin-2-yl]-benzamide or a pharmaceutically acceptable salt thereof formulated for: oral or rectal administration of 50 to 400 mg per dose of 2,4,6-trifluoro-N-[6-(1-methylpiperdin-4-ylcarbonyl)-pyridin-2-yl]-benzamide or a pharmaceutically acceptable salt thereof or buccal, sublingual, nasal/intranasal, transdermal, subcutaneous, injectable, intravenous or intramuscular administration of 20 to 60 mg per dose of 2,4,6-trifluoro-N-[6-(1-methylpiperdin-4-ylcarbonyl)-pyridin-2-yl]-benzamide or a pharmaceutically acceptable salt thereof and the use of said pharmaceutical composition in the treatment or prevention of migraine.
